{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T07:02:09Z","timestamp":1794898929801,"version":"4.9.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"38","license":[{"start":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T00:00:00Z","timestamp":1527552000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1038\/s41388-018-0325-x","type":"journal-article","created":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T08:07:22Z","timestamp":1527581242000},"page":"5175-5190","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Loss of MAOA in epithelia inhibits adenocarcinoma development, cell proliferation and cancer stem cells in prostate"],"prefix":"10.1038","volume":"37","author":[{"given":"Chun-Peng","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Ping","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Chuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren A.","family":"Geary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijaya Pooja","family":"Vaikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason Boyang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Hung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell E.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean C.","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,29]]},"reference":[{"key":"325_CR1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev.neuro.22.1.197","volume":"22","author":"JC Shih","year":"1999","unstructured":"Shih JC, Chen K, Ridd MJ. Monoamine oxidase: from genes to behavior. Annu Rev Neurosci. 1999;22:197\u2013217.","journal-title":"Annu Rev Neurosci"},{"key":"325_CR2","doi-asserted-by":"publisher","first-page":"12816","DOI":"10.1073\/pnas.1308037110","volume":"110","author":"C Singh","year":"2013","unstructured":"Singh C, Bortolato M, Bali N, Godar SC, Scott AL, Chen K, et al. Cognitive abnormalities and hippocampal alterations in monoamine oxidase A and B knockout mice. Proc Natl Acad Sci USA. 2013;110:12816\u201321.","journal-title":"Proc Natl Acad Sci USA"},{"key":"325_CR3","doi-asserted-by":"publisher","first-page":"4934","DOI":"10.1073\/pnas.85.13.4934","volume":"85","author":"AW Bach","year":"1988","unstructured":"Bach AW, Lan NC, Johnson DL, Abell CW, Bembenek ME, Kwan SW, et al. cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties. Proc Natl Acad Sci USA. 1988;85:4934\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"325_CR4","doi-asserted-by":"publisher","first-page":"10991","DOI":"10.1073\/pnas.0603678103","volume":"103","author":"L True","year":"2006","unstructured":"True L, Coleman I, Hawley S, Huang CY, Gifford D, Coleman R, et al. A molecular correlate to the Gleason grading system for prostate adenocarcinoma. Proc Natl Acad Sci USA. 2006;103:10991\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"325_CR5","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1016\/j.juro.2008.07.019","volume":"180","author":"DM Peehl","year":"2008","unstructured":"Peehl DM, Coram M, Khine H, Reese S, Nolley R, Zhao H. The significance of monoamine oxidase-A expression in high grade prostate cancer. J Urol. 2008;180:2206\u201311.","journal-title":"J Urol"},{"key":"325_CR6","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1172\/JCI70982","volume":"124","author":"JB Wu","year":"2014","unstructured":"Wu JB, Shao C, Li X, Li Q, Hu P, Shi C, et al. Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis. J Clin Investig. 2014;124:2891\u2013908.","journal-title":"J Clin Investig"},{"key":"325_CR7","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1021\/ja512613j","volume":"137","author":"JB Wu","year":"2015","unstructured":"Wu JB, Lin TP, Gallagher JD, Kushal S, Chung LW, Zhau HE, et al. Monoamine oxidase A inhibitor-near-infrared dye conjugate reduces prostate tumor growth. J Am Chem Soc. 2015;137:2366\u201374.","journal-title":"J Am Chem Soc"},{"key":"325_CR8","doi-asserted-by":"publisher","first-page":"13842","DOI":"10.18632\/oncotarget.7283","volume":"7","author":"S Kushal","year":"2016","unstructured":"Kushal S, Wang W, Vaikari VP, Kota R, Chen K, Yeh TS, et al. Monoamine oxidase A (MAO A) inhibitors decrease glioma progression. Oncotarget. 2016;7:13842\u201353.","journal-title":"Oncotarget"},{"key":"325_CR9","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/path.4944","volume":"243","author":"PC Li","year":"2017","unstructured":"Li PC, Siddiqi IN, Mottok A, Loo EY, Wu CH, Cozen W, et al. Monoamine oxidase A is highly expressed in classical Hodgkin lymphoma. J Pathol. 2017;243:220\u20139.","journal-title":"J Pathol"},{"key":"325_CR10","first-page":"7","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA: A Cancer J Clin. 2017;67:7\u201330.","journal-title":"CA: A Cancer J Clin"},{"key":"325_CR11","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1126\/science.275.5308.1943","volume":"275","author":"J Li","year":"1997","unstructured":"Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 1997;275:1943\u20137.","journal-title":"Science"},{"key":"325_CR12","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1146\/annurev.pathol.4.110807.092311","volume":"4","author":"N Chalhoub","year":"2009","unstructured":"Chalhoub N, Baker SJ. PTEN and the PI3-kinase pathway in cancer. Annu Rev Pathol. 2009;4:127\u201350.","journal-title":"Annu Rev Pathol"},{"key":"325_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0925-4773(00)00551-7","volume":"101","author":"X Wu","year":"2001","unstructured":"Wu X, Wu J, Huang J, Powell WC, Zhang J, Matusik RJ, et al. Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation. Mech Dev. 2001;101:61\u20139.","journal-title":"Mech Dev"},{"key":"325_CR14","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S1535-6108(03)00215-0","volume":"4","author":"S Wang","year":"2003","unstructured":"Wang S, Gao J, Lei Q, Rozengurt N, Pritchard C, Jiao J, et al. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell. 2003;4:209\u201321.","journal-title":"Cancer Cell"},{"key":"325_CR15","doi-asserted-by":"publisher","first-page":"19444","DOI":"10.1073\/pnas.0807691105","volume":"105","author":"Y Fu","year":"2008","unstructured":"Fu Y, Wey S, Wang M, Ye R, Liao CP, Roy-Burman P, et al. Pten null prostate tumorigenesis and AKT activation are blocked by targeted knockout of ER chaperone GRP78\/BiP in prostate epithelium. Proc Natl Acad Sci USA. 2008;105:19444\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"325_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0069484","volume":"8","author":"H Adisetiyo","year":"2013","unstructured":"Adisetiyo H, Liang M, Liao CP, Aycock-Williams A, Cohen MB, Xu S, et al. Loss of survivin in the prostate epithelium impedes carcinogenesis in a mouse model of prostate adenocarcinoma. PLoS ONE. 2013;8:e69484.","journal-title":"PLoS ONE"},{"key":"325_CR17","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/0014-5793(93)81512-X","volume":"317","author":"J Gottowik","year":"1993","unstructured":"Gottowik J, Cesura AM, Malherbe P, Lang G, Da Prada M. Characterisation of wild-type and mutant forms of human monoamine oxidase A and B expressed in a mammalian cell line. FEBS Lett. 1993;317:152\u20136.","journal-title":"FEBS Lett"},{"key":"325_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/oxfordjournals.jbchem.a003064","volume":"131","author":"J Ma","year":"2002","unstructured":"Ma J, Ito A. Tyrosine residues near the FAD binding site are critical for FAD binding and for the maintenance of the stable and active conformation of rat monoamine oxidase A. J Biochem. 2002;131:107\u201311.","journal-title":"J Biochem"},{"key":"325_CR19","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1038\/npp.2011.157","volume":"36","author":"M Bortolato","year":"2011","unstructured":"Bortolato M, Chen K, Godar SC, Chen G, Wu W, Rebrin I, et al. Social deficits and perseverative behaviors, but not overt aggression, in MAO-A hypomorphic mice. Neuropsychopharmacology. 2011;36:2674\u201388.","journal-title":"Neuropsychopharmacology"},{"key":"325_CR20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2174\/1389450114666140106100909","volume":"15","author":"LM Dillon","year":"2014","unstructured":"Dillon LM, Miller TW. Therapeutic targeting of cancers with loss of PTEN function. Curr Drug Targets. 2014;15:65\u201379.","journal-title":"Curr Drug Targets"},{"key":"325_CR21","doi-asserted-by":"publisher","first-page":"R56","DOI":"10.1186\/bcr2615","volume":"12","author":"VJ Tuominen","year":"2010","unstructured":"Tuominen VJ, Ruotoistenmaki S, Viitanen A, Jumppanen M, Isola J. ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67. Breast Cancer Res. 2010;12:R56.","journal-title":"Breast Cancer Res"},{"key":"325_CR22","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1073\/pnas.0810956106","volume":"106","author":"A Dubrovska","year":"2009","unstructured":"Dubrovska A, Kim S, Salamone RJ, Walker JR, Maira SM, Garcia-Echeverria C, et al. The role of PTEN\/Akt\/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations. Proc Natl Acad Sci USA. 2009;106:268\u201373.","journal-title":"Proc Natl Acad Sci USA"},{"key":"325_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094621","volume":"9","author":"SH Sahlberg","year":"2014","unstructured":"Sahlberg SH, Spiegelberg D, Glimelius B, Stenerlow B, Nestor M. Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells. PLoS ONE. 2014;9:e94621.","journal-title":"PLoS ONE"},{"key":"325_CR24","first-page":"1101","volume":"28","author":"S Dawood","year":"2014","unstructured":"Dawood S, Austin L, Cristofanilli M. Cancer stem cells: implications for cancer therapy. Oncology (Williston Park). 2014;28:1101\u20137.","journal-title":"Oncology (Williston Park)"},{"key":"325_CR25","doi-asserted-by":"publisher","first-page":"10946","DOI":"10.1158\/0008-5472.CAN-05-2018","volume":"65","author":"AT Collins","year":"2005","unstructured":"Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005;65:10946\u201351.","journal-title":"Cancer Res"},{"key":"325_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.gde.2003.11.007","volume":"14","author":"M Al-Hajj","year":"2004","unstructured":"Al-Hajj M, Becker MW, Wicha M, Weissman I, Clarke MF. Therapeutic implications of cancer stem cells. Curr Opin Genet Dev. 2004;14:43\u20137.","journal-title":"Curr Opin Genet Dev"},{"key":"325_CR27","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1038\/labinvest.3700488","volume":"86","author":"BT Tan","year":"2006","unstructured":"Tan BT, Park CY, Ailles LE, Weissman IL. The cancer stem cell hypothesis: a work in progress. Lab Investig. 2006;86:1203\u20137.","journal-title":"Lab Investig"},{"key":"325_CR28","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.stem.2010.02.014","volume":"6","author":"DL Berg van den","year":"2010","unstructured":"van den Berg DL, Snoek T, Mullin NP, Yates A, Bezstarosti K, Demmers J, et al. An Oct4-centered protein interaction network in embryonic stem cells. Cell Stem Cell. 2010;6:369\u201381.","journal-title":"Cell Stem Cell"},{"key":"325_CR29","first-page":"2720","volume":"58","author":"RJ Vlietstra","year":"1998","unstructured":"Vlietstra RJ, van Alewijk DC, Hermans KG, van Steenbrugge GJ, Trapman J. Frequent inactivation of PTEN in prostate cancer cell lines and xenografts. Cancer Res. 1998;58:2720\u20133.","journal-title":"Cancer Res"},{"key":"325_CR30","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.stem.2010.06.020","volume":"7","author":"K Takubo","year":"2010","unstructured":"Takubo K, Goda N, Yamada W, Iriuchishima H, Ikeda E, Kubota Y, et al. Regulation of the HIF-1alpha level is essential for hematopoietic stem cells. Cell Stem Cell. 2010;7:391\u2013402.","journal-title":"Cell Stem Cell"},{"key":"325_CR31","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1038\/leu.2015.8","volume":"29","author":"CE Forristal","year":"2015","unstructured":"Forristal CE, Nowlan B, Jacobsen RN, Barbier V, Walkinshaw G, Walkley CR, et al. HIF-1alpha is required for hematopoietic stem cell mobilization and 4-prolyl hydroxylase inhibitors enhance mobilization by stabilizing HIF-1alpha. Leukemia. 2015;29:1366\u201378.","journal-title":"Leukemia"},{"key":"325_CR32","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2:401\u20134.","journal-title":"Cancer Discov"},{"key":"325_CR33","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6:pl1.","journal-title":"Sci Signal"},{"key":"325_CR34","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.eururo.2015.06.046","volume":"69","author":"JI Epstein","year":"2016","unstructured":"Epstein JI, Zelefsky MJ, Sjoberg DD, Nelson JB, Egevad L, Magi-Galluzzi C, et al. A contemporary prostate cancer grading system: a validated alternative to the Gleason score. Eur Urol. 2016;69:428\u201335.","journal-title":"Eur Urol"},{"key":"325_CR35","first-page":"8","volume":"16","author":"DS Oliveira","year":"2016","unstructured":"Oliveira DS, Dzinic S, Bonfil AI, Saliganan AD, Sheng S, Bonfil RD. The mouse prostate: a basic anatomical and histological guideline. Bosn J Basic Med Sci. 2016;16:8\u201313.","journal-title":"Bosn J Basic Med Sci"},{"key":"325_CR36","doi-asserted-by":"publisher","first-page":"7525","DOI":"10.1158\/0008-5472.CAN-07-0668","volume":"67","author":"CP Liao","year":"2007","unstructured":"Liao CP, Zhong C, Saribekyan G, Bading J, Park R, Conti PS, et al. Mouse models of prostate adenocarcinoma with the capacity to monitor spontaneous carcinogenesis by bioluminescence or fluorescence. Cancer Res. 2007;67:7525\u201333.","journal-title":"Cancer Res"},{"key":"325_CR37","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1073\/pnas.96.11.6199","volume":"96","author":"H Sun","year":"1999","unstructured":"Sun H, Lesche R, Li DM, Liliental J, Zhang H, Gao J, et al. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt\/protein kinase B signaling pathway. Proc Natl Acad Sci USA. 1999;96:6199\u2013204.","journal-title":"Proc Natl Acad Sci USA"},{"key":"325_CR38","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/ng.556","volume":"42","author":"A Alimonti","year":"2010","unstructured":"Alimonti A, Carracedo A, Clohessy JG, Trotman LC, Nardella C, Egia A, et al. Subtle variations in Pten dose determine cancer susceptibility. Nat Genet. 2010;42:454\u20138.","journal-title":"Nat Genet"},{"key":"325_CR39","doi-asserted-by":"publisher","first-page":"4807","DOI":"10.1158\/0008-5472.CAN-06-4608","volume":"67","author":"G Gu","year":"2007","unstructured":"Gu G, Yuan J, Wills M, Kasper S. Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. Cancer Res. 2007;67:4807\u201315.","journal-title":"Cancer Res"},{"key":"325_CR40","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1101\/sqb.2005.70.003","volume":"70","author":"DA Lawson","year":"2005","unstructured":"Lawson DA, Xin L, Lukacs R, Xu Q, Cheng D, Witte ON. Prostate stem cells and prostate cancer. Cold Spring Harb Symp Quant Biol. 2005;70:187\u201396.","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"325_CR41","first-page":"1043","volume":"22","author":"AY Nikitin","year":"2007","unstructured":"Nikitin AY, Matoso A, Roy-Burman P. Prostate stem cells and cancer. Histol Histopathol. 2007;22:1043\u20139.","journal-title":"Histol Histopathol"},{"key":"325_CR42","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.eururo.2009.01.015","volume":"57","author":"MJ Pfeiffer","year":"2010","unstructured":"Pfeiffer MJ, Schalken JA. Stem cell characteristics in prostate cancer cell lines. Eur Urol. 2010;57:246\u201354.","journal-title":"Eur Urol"},{"key":"325_CR43","doi-asserted-by":"publisher","first-page":"7294","DOI":"10.1158\/0008-5472.CAN-09-3982","volume":"70","author":"CP Liao","year":"2010","unstructured":"Liao CP, Adisetiyo H, Liang M, Roy-Burman P. Cancer-associated fibroblasts enhance the gland-forming capability of prostate cancer stem cells. Cancer Res. 2010;70:7294\u2013303.","journal-title":"Cancer Res"},{"key":"325_CR44","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s12672-010-0051-5","volume":"1","author":"CP Liao","year":"2010","unstructured":"Liao CP, Adisetiyo H, Liang M, Roy-Burman P. Cancer stem cells and microenvironment in prostate cancer progression. Horm Cancer. 2010;1:297\u2013305.","journal-title":"Horm Cancer"},{"key":"325_CR45","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1002\/jcp.24546","volume":"229","author":"H Adisetiyo","year":"2014","unstructured":"Adisetiyo H, Liang M, Liao CP, Jeong JH, Cohen MB, Roy-Burman P, et al. Dependence of castration-resistant prostate cancer (CRPC) stem cells on CRPC-associated fibroblasts. J Cell Physiol. 2014;229:1170\u20136.","journal-title":"J Cell Physiol"},{"key":"325_CR46","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1242\/dmm.008458","volume":"5","author":"MC Ting","year":"2012","unstructured":"Ting MC, Liao CP, Yan C, Jia L, Groshen S, Frenkel B, et al. An enhancer from the 8q24 prostate cancer risk region is sufficient to direct reporter gene expression to a subset of prostate stem-like epithelial cells in transgenic mice. Dis Models Mech. 2012;5:366\u201374.","journal-title":"Dis Models Mech"},{"key":"325_CR47","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1126\/science.1189992","volume":"329","author":"AS Goldstein","year":"2010","unstructured":"Goldstein AS, Huang J, Guo C, Garraway IP, Witte ON. Identification of a cell of origin for human prostate cancer. Science. 2010;329:568\u201371.","journal-title":"Science"},{"key":"325_CR48","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/nature07427","volume":"456","author":"KG Leong","year":"2008","unstructured":"Leong KG, Wang BE, Johnson L, Gao WQ. Generation of a prostate from a single adult stem cell. Nature. 2008;456:804\u20138.","journal-title":"Nature"},{"key":"325_CR49","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/bjc.2015.228","volume":"113","author":"S Xu","year":"2015","unstructured":"Xu S, Adisetiyo H, Tamura S, Grande F, Garofalo A, Roy-Burman P, et al. Dual inhibition of survivin and MAOA synergistically impairs growth of PTEN-negative prostate cancer. British Journal of Cancer. 2015;113:242\u201351.","journal-title":"British Journal of Cancer"},{"key":"325_CR50","unstructured":"The Cancer Genome Atlas Research Network. The molecular taxonomy of primary prostate cancer. Cell. 2015;163:1011\u201325.."}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41388-018-0325-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-018-0325-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-018-0325-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:12:07Z","timestamp":1684617127000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-018-0325-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,29]]},"references-count":50,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["325"],"URL":"https:\/\/doi.org\/10.1038\/s41388-018-0325-x","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,29]]},"assertion":[{"value":"21 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}